159 related articles for article (PubMed ID: 21258798)
1. Increased serum RANTES in patients with systemic lupus erythematosus.
Lu MM; Wang J; Pan HF; Chen GM; Li J; Cen H; Feng CC; Ye DQ
Rheumatol Int; 2012 May; 32(5):1231-3. PubMed ID: 21258798
[TBL] [Abstract][Full Text] [Related]
2. Nonrenal and renal activity of systemic lupus erythematosus: a comparison of two anti-C1q and five anti-dsDNA assays and complement C3 and C4.
Julkunen H; Ekblom-Kullberg S; Miettinen A
Rheumatol Int; 2012 Aug; 32(8):2445-51. PubMed ID: 21706294
[TBL] [Abstract][Full Text] [Related]
3. Urine neopterin as a parameter of disease activity in patients with systemic lupus erythematosus: comparisons with serum sIL-2R and antibodies to dsDNA, erythrocyte sedimentation rate, and plasma C3, C4, and C3 degradation products.
Lim KL; Jones AC; Brown NS; Powell RJ
Ann Rheum Dis; 1993 Jun; 52(6):429-35. PubMed ID: 8323394
[TBL] [Abstract][Full Text] [Related]
4. Anti-CII antibody as a novel indicator to assess disease activity in systemic lupus erythematosus.
He C; Mao T; Feng Y; Song T; Qin C; Yan R; Feng P
Lupus; 2015 Nov; 24(13):1370-6. PubMed ID: 26048288
[TBL] [Abstract][Full Text] [Related]
5. Autoantibodies to box A of high mobility group box 1 in systemic lupus erythematosus.
Schaper F; de Leeuw K; Horst G; Maas F; Bootsma H; Heeringa P; Limburg PC; Westra J
Clin Exp Immunol; 2017 Jun; 188(3):412-419. PubMed ID: 28245520
[TBL] [Abstract][Full Text] [Related]
6. Association of Serum Ferritin Levels with Hematological Manifestations in Systemic Lupus Erythematosus Patients from Western India.
Pradhan V; Pandit P; Rajadhyaksha A; Patwardhan M; Surve P; Kamble P; Lecerf M; Bayry J; Kaveri S; Ghosh K; Nadkar MY
J Assoc Physicians India; 2016 May; 64(5):14-18. PubMed ID: 27735143
[TBL] [Abstract][Full Text] [Related]
7. Immunological and clinical differences between juvenile and adult onset of systemic lupus erythematosus.
Carreño L; López-Longo FJ; Monteagudo I; Rodríguez-Mahou M; Bascones M; González CM; Saint-Cyr C; Lapointe N
Lupus; 1999; 8(4):287-92. PubMed ID: 10413207
[TBL] [Abstract][Full Text] [Related]
8. Soluble TNF-R1, VEGF and other cytokines as markers of disease activity in systemic lupus erythematosus and lupus nephritis.
Adhya Z; El Anbari M; Anwar S; Mortimer A; Marr N; Karim MY
Lupus; 2019 May; 28(6):713-721. PubMed ID: 31046570
[TBL] [Abstract][Full Text] [Related]
9. [Serum free light chains for monitoring systemic lupus erythematosus activity].
Żychowska I; Suszek D; Dryglewska M; Nurzyńska D; Donica H; Majdan M
Wiad Lek; 2018; 71(1 pt 1):21-31. PubMed ID: 29558348
[TBL] [Abstract][Full Text] [Related]
10. Elevated interleukin-10 levels correlated with disease activity in systemic lupus erythematosus.
Park YB; Lee SK; Kim DS; Lee J; Lee CH; Song CH
Clin Exp Rheumatol; 1998; 16(3):283-8. PubMed ID: 9631750
[TBL] [Abstract][Full Text] [Related]
11. CD69 to CD3 ratio of peripheral blood mononuclear cells as a marker to monitor systemic lupus erythematosus disease activity.
Su CC; Shau WY; Wang CR; Chuang CY; Chen CY
Lupus; 1997; 6(5):449-54. PubMed ID: 9229364
[TBL] [Abstract][Full Text] [Related]
12. Measurement of serum interferon alpha in Egyptian patients with systemic lupus erythematosus and evaluation of its effect on disease activity: a case-control study.
Fayed A; El Menyawi MM; Ghanema M; Shaker O; Elgohary R
Reumatismo; 2020 Nov; 72(3):145-153. PubMed ID: 33213127
[TBL] [Abstract][Full Text] [Related]
13. [The role of anti-nucleosome antibodies in systemic lupus erythematosus. Results of a study of patients with systemic lupus erythematosus and other connective tissue diseases].
Quattrocchi P; Barrile A; Bonanno D; Giannetto L; Patafi M; Tigano V; Ferlazzo B
Reumatismo; 2005; 57(2):109-13. PubMed ID: 15983634
[TBL] [Abstract][Full Text] [Related]
14. Hematocrit Level could Reflect Inflammatory Response and Disease Activity in Patients with Systemic Lupus Erythematosus.
Yang M; Ma N; Fu H; Wei T; Tang Q; Qin B; Yang Z; Zhong R
Clin Lab; 2015; 61(7):801-7. PubMed ID: 26299080
[TBL] [Abstract][Full Text] [Related]
15. Serum human epididymis protein 4 is a predictor for developing nephritis in patients with systemic lupus erythematosus: A prospective cohort study.
Ren Y; Xie J; Lin F; Luo W; Zhang Z; Mao P; Zhong R; Liang Y; Yang Z
Int Immunopharmacol; 2018 Jul; 60():189-193. PubMed ID: 29747124
[TBL] [Abstract][Full Text] [Related]
16. Progressive reduction of serum complement levels: a risk factor for relapse in patients with hypocomplementemia in systemic lupus erythematosus.
Miyawaki Y; Sada K; Asano Y; Hayashi K; Yamamura Y; Hiramatsu S; Ohashi K; Morishita M; Watanabe H; Matsumoto Y; Kawabata T; Wada J
Lupus; 2018 Nov; 27(13):2093-2100. PubMed ID: 30309286
[TBL] [Abstract][Full Text] [Related]
17. Association of serum MIP-1alpha, MIP-1beta, and RANTES with clinical manifestations, disease activity, and damage accrual in systemic lupus erythematosus.
Vilá LM; Molina MJ; Mayor AM; Cruz JJ; Ríos-Olivares E; Ríos Z
Clin Rheumatol; 2007 May; 26(5):718-22. PubMed ID: 16924394
[TBL] [Abstract][Full Text] [Related]
18. A study on the association of autoantibodies, chemokine, and its receptor with disease activity in systemic lupus erythematosus in North Indian population.
Bidyalaxmi Devi L; Bhatnagar A; Wanchu A; Sharma A
Rheumatol Int; 2013 Nov; 33(11):2819-26. PubMed ID: 23832290
[TBL] [Abstract][Full Text] [Related]
19. Elevated serum interleukin-34 level in juvenile systemic lupus erythematosus and disease activity.
El-Banna HS; El Khouly RM; Gado SE
Clin Rheumatol; 2020 May; 39(5):1627-1632. PubMed ID: 31907692
[TBL] [Abstract][Full Text] [Related]
20. T cell subsets and immunoglobulin G levels are associated with the infection status of systemic lupus erythematosus patients.
Wu L; Wang X; Chen F; Lv X; Sun W; Guo Y; Hou H; Ji H; Wei W; Gong L
Braz J Med Biol Res; 2017 Dec; 51(2):e4547. PubMed ID: 29267496
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
